Synopsys stock keeps focus on stronger long-term growth outlook – ad-hoc

By Nov 9, 2026

S&P Global Ratings — Synopsys stock keeps focus on stronger long-term growth outlook ad-hoc-news.de

Read the original at S&P Global Ratings ↗

Auto-published by the finit.news Events monitor from S&P Global Ratings; summarized by AI and may contain errors — verify against the primary source. November 9, 2026.

By

Credit Ratings

Fitch affirms Iraq at ’B-’ with stable outlook as reserves offset oil shock

Nov 9, 2026

Credit Ratings

Fitch Ratings revises AFL’s outlook to Negative

Nov 9, 2026

Credit Ratings

Kcell : Fitch Ratings upgrades credit rating of Kcell JSC to investment grade “BBB−”, Outlook Stable

Nov 9, 2026

Synopsys stock keeps focus on stronger long-term growth outlook – ad-hoc

By

Financial News For All

Hundreds of Portland employees on strike Monday after bargaining falls through

More than 800 Portland workers are on strike over wages – Oregon Public Broadcasting

After a 10-year gap, FDA approves new option for pretreated head and neck cancer

Novocure denied FDA approval for metastatic cancer treatment

Synopsys stock keeps focus on stronger long-term growth outlook – ad-hoc

By

Related Post

Fitch affirms Iraq at ’B-’ with stable outlook as reserves offset oil shock

Fitch Ratings revises AFL’s outlook to Negative

Kcell : Fitch Ratings upgrades credit rating of Kcell JSC to investment grade “BBB−”, Outlook Stable

Financial News For All

Hundreds of Portland employees on strike Monday after bargaining falls through

More than 800 Portland workers are on strike over wages – Oregon Public Broadcasting

After a 10-year gap, FDA approves new option for pretreated head and neck cancer

Novocure denied FDA approval for metastatic cancer treatment